Evidence map›Paper›PMID 35026696›Full record

ArticleCancer genetics2022

Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.

Annie Garcia, Lauren Desrosiers, Sarah Scollon, Stephanie Gruner, Jacquelyn Reuther, Ilavarasi Gandhi, Ninad Patil, Maren Y Fuller, Hongzheng Dai, Donna Muzny and 9 more

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Annie GarciaDepartment of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX USA.
Lauren DesrosiersTexas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA.
Sarah ScollonTexas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA.
Stephanie GrunerTexas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA.
Jacquelyn ReutherDepartment of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX USA.
Ilavarasi GandhiDepartment of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX USA.
Ninad PatilDepartment of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX USA.
Maren Y FullerDepartment of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX USA.
Hongzheng DaiDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA.
Donna MuznyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX USA.
Richard A GibbsDan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX USA.
Jennifer L Bercaw-PrattDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX USA.
Seema L RaoTexas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA.
Nino RainussoTexas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX USA.
Kevin E FisherDepartment of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX USA; Texas Children's Cancer Center, Houston, TX USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX USA.
Frank Y LinTexas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX USA.
Sharon E PlonTexas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA.
D Williams ParsonsDepartment of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX USA; Texas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX USA.
Angshumoy RoyDepartment of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Texas Children's Hospital, Houston, TX USA; Texas Children's Cancer Center, Houston, TX USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX USA; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX USA. Electronic address: aroy@bcm.edu.
Baylor College of Medicine · US

Funding

Measuring Perceptions of Utility of Clinical Genome Sequencing: Instrument Testing and ValidationU01HG006485 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI MCGUIRE, AMY L, PARSONS, DONALD W. · 2012 to 2021
$22.1M
NHGRI NIH HHS U01 HG006485
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DEAD-box RNA HelicasesOvarian NeoplasmsRibonuclease IIISertoli-Leydig Cell TumorFemaleHumansMutationDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease IIIDICER1MosaicPathogenicRNase IIIbSertoli-Leydig

Identifiers

PMID35026696
PMCPMC8920771
OpenAlexW4205265180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.